Hydroxychloroquine versus Azithromycin for Hospitalized Patients with Suspected or Confirmed COVID-19 (HAHPS). Protocol for a Pragmatic, Open-Label, Active Comparator Trial

Coronavirus disease (COVID-19) is a potentially fatal illness with no proven therapy beyond excellent supportive care. Treatments are urgently sought. Adaptations to traditional trial logistics and design to allow rapid implementation, evaluation of trials within a global trials context, flexible in...

Descripción completa

Detalles Bibliográficos
Autores principales: Brown, Samuel M., Peltan, Ithan D., Webb, Brandon, Kumar, Naresh, Starr, Nathan, Grissom, Colin, Buckel, Whitney R., Srivastava, Raj, Harris, Estelle S., Leither, Lindsay M., Johnson, Stacy A., Paine, Robert, Greene, Tom
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Thoracic Society 2020
Materias:
Clinical Study Design
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7393787/
https://www.ncbi.nlm.nih.gov/pubmed/32425051
http://dx.doi.org/10.1513/AnnalsATS.202004-309SD

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7393787/
https://www.ncbi.nlm.nih.gov/pubmed/32425051
http://dx.doi.org/10.1513/AnnalsATS.202004-309SD

Ejemplares similares